IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages
Li-Zong Rao,Yi Wang,Lei Zhang,Guorao Wu,Lu Zhang,Fa-Xi Wang,Long-Min Chen,Fei Sun,Song Jia,Shu Zhang,Qilin Yu,Jiang-Hong Wei,Hui-Ren Lei,Ting Yuan,Jinxiu Li,Xingxu Huang,Bin Cheng,Jianping Zhao,Yongjian Xu,Bi-Wen Mo,Cong-Yi Wang,Huilan Zhang
DOI: https://doi.org/10.1038/s41418-020-00650-6
IF: 12.067
2020-11-03
Cell Death and Differentiation
Abstract:Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia and has one of the poorest prognosis. However, the molecular mechanisms underlying IPF progression remain largely unknown. In this study, we determined that IL-24, an IL-20 subfamily cytokine member, was increased both in the serum of IPF patients and the bronchoalveolar lavage fluid (BALF) of mice following bleomycin (BLM)-induced pulmonary fibrosis. As a result, <i>IL-24</i> deficiency protected mice from BLM-induced lung injury and fibrosis. Specifically, loss of <i>IL-24</i> significantly attenuated transforming growth factor β1 (TGF-β1) production and reduced M2 macrophage infiltration in the lung of BLM-induced mice. Mechanistically, IL-24 alone did not show a perceptible impact on the induction of M2 macrophages, but it synergized with IL-4 to promote M2 program in macrophages. IL-24 suppressed IL-4-induced expression of suppressor of cytokine signaling 1 (SOCS1) and SOCS3, through which it enhanced signal transducer and activator of transcription 6/peroxisome proliferator-activated receptor gamma (STAT6/PPARγ) signaling, thereby promoting IL-4-induced production of M2 macrophages. Collectively, our data support that IL-24 synergizes with IL-4 to promote macrophage M2 program contributing to the development of pulmonary fibrosis.
cell biology,biochemistry & molecular biology